(Q73202188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

D N Enomoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J R Mekkes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P M Bossuyt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S L Yong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T A Out

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Hoekzema

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M A de Rie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P T Schellekens

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I J ten Berge

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C A de Borgie

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J D Bos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

915-922

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of scleroderma

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Epidemiology of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

1 reference

7 January 2021

Treatment of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Update on scleroderma.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Extracorporeal photochemotherapy in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Parenteral administration of 8-methoxypsoralen in photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Dosage guidelines: extracorporeal photochemotherapy (photopheresis)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

The Frenchay Activities Index. Assessment of functional status in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

The aetiopathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

A brief overview of the pathogenesis of scleroderma (systemic sclerosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Systemic scleroderma. Clinical and pathophysiologic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

The pathophysiology of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

The control of fibrosis in systemic sclerosis: a strategy involving extracellular matrix, cytokines, and growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Immunologic aspects of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Cytokine production and serum levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Interleukin-1, Interleukin-2, Interleukin-4, Interleukin-6, Tumor Necrosis Factor α, and Interferon-γ Levels in Sera from Patients With Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

The immunogenetic background of scleroderma--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Differential modulation of bFGF receptors by TGF-beta in adult skin, scleroderma skin, and newborn foreskin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Enhanced production of transforming growth factor-beta (TGF-beta) during autologous mixed lymphocyte reaction of systemic sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Response of scleroderma fibroblasts to various growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970246-X

7 January 2021

10.1016/S0190-9622(99)70246-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10570373%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference